Failure by any person exploiting a medicinal product or product to communicate any new information likely to influence the assessment of the benefits and risks of the medicinal product or product concerned pursuant to article L. 5121-9-2 or to transmit the data requested by the Agency within the time limits set by it pursuant to article L. 5121-9-3 is punishable by two years’ imprisonment and a fine of €150,000.